8-K

As Filed with the Securities and Exchange Commission on September 23, 2015

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 23, 2015 (September 22, 2015)

MONSANTO COMPANY

(Exact Name of Registrant as Specified in its Charter)

Delaware	001-16167	43-1878297
(State of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

800 North Lindbergh Boulevard

St. Louis, Missouri 63167

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (314) 694-1000

Not Applicable

(Former Name or Former Address, If Changed Since Last Report)

_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d.-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 22, 2015, Monsanto Company’s Board of Directors elected Patricia D. Verduin, Ph.D. to the Board of Directors and appointed Dr. Verduin to its Science and Technology Committee and its Sustainability and Corporate Responsibility Committee. Dr. Verduin is the Vice President and Chief Technology Officer of Colgate Palmolive Company. Dr. Verduin will stand for election at the Company’s 2016 annual meeting of shareowners.

In addition, the Board determined that Dr. Verduin is independent under the listing standards of the New York Stock Exchange (“NYSE”) and the Board’s charter and corporate governance guidelines.

Dr. Verduin will be entitled to receive the same compensation for service as a director as is provided to other directors of the Company under the Non-Employee Director Equity Incentive Compensation Plan (the “Plan”). The Plan was described in more detail in the Proxy Statement for our 2015 annual meeting. Under the Plan, Dr. Verduin will receive an annual retainer, which for fiscal 2016 is $245,000. Half of the aggregate retainer is payable in deferred common stock, and the remainder is payable, at the election of each director, in the form of restricted common stock, deferred common stock, current cash and/or deferred cash. Pursuant to the Plan, Dr. Verduin was also provided a grant of restricted stock upon commencement of service as a member of the Board of Directors equal to the full annual base retainer divided by the closing price of a share of the Company’s common stock on the commencement date, which amounted to 2,832shares of restricted stock.

A press release announcing the election of Dr. Verduin as a director, as described above, is attached as Exhibit 99.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

The following documents are filed as exhibits to this report:

Exhibit 99Press Release dated September 22, 2015

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: September 23, 2015

MONSANTO COMPANY
By:	/s/ Michelle Bushore
Name:	Michelle Bushore
Title:	Assistant Secretary

3

EXHIBIT INDEX

Exhibit No.	Description of Exhibit
99	Press Release dated September 22, 2015

EX-99

Exhibit 99

Monsanto Company

800 North Lindbergh Blvd

St. Louis, Missouri 63167

Release	Immediately
Contact	Media:      Sara Miller  (314-694-5824)

MONSANTO COMPANY ADDS PATRICIA VERDUIN, PH.D., TO BOARD OF DIRECTORS

ST. LOUIS (September 22, 2015) - Monsanto Company (NYSE: MON) announced today the appointment of Patricia Verduin, Ph.D., to the company’s board of directors. Dr. Verduin is vice president and chief technology officer of Colgate-Palmolive Company, a global consumer products company. In her role, she leads the development of Colgate’s products and technologies, including responsibility for product safety, quality and regulatory matters. She joined Colgate in 2007, first serving as vice president of global research and development before assuming her current role in 2011.

Prior to joining Colgate, Dr. Verduin was senior vice president and chief science officer for the Grocery Manufacturers Association, and senior vice president of product quality and development at ConAgra Foods, Inc. She also previously held a variety of senior technical and operational positions at Nabisco, International Home Foods and Lipton. Dr. Verduin has held a variety of senior technical and operational positions at ConAgra Foods, Nabisco, International Home Foods and Lipton. Dr. Verduin has held a variety of senior technical and operational positions at ConAgra Foods, Nabisco, International Home Foods and Lipton. Dr. Verduin has held a variety of senior technical and operational positions at ConAgra Foods, Nabisco, International Home Foods and Lipton.

“On behalf of Monsanto, I am pleased to welcome Dr. Verduin as an independent director to our board,” said Hugh Grant, Monsanto’s chairman of the board and chief executive officer. “Her impressive experience leading research at top companies and organizations will enable her to provide valuable insight to our board on a variety of matters, including how we continue to deliver a broad range of innovative solutions to help nourish our growing world.”

Dr. Verduin’s appointment is effective immediately, and she will stand for election to the board at the 2016 annual meeting of shareowners. She will serve on the science and technology committee and sustainability and corporate responsibility committee.

Dr. Verduin holds a bachelor of science degree in food science from the University of Delaware, a MBA in finance from Farleigh Dickinson University and a Ph.D. in food science from Rutgers University.

The addition of Dr. Verduin to Monsanto’s board brings the number of directors to 14, with 13 independent directors. Additional information on Monsanto’s Board of Directors can be accessed at http://www.monsanto.com/whoweare/Pages/board-of-directors.aspx. For more information on Monsanto’s board committees, visit http://www.monsanto.com/whoweare/Pages/corporate-governance.aspx.

About Monsanto Company

Monsanto is committed to bringing a broad range of solutions to help nourish our growing world. We produce seeds for fruits, vegetables and key crops - such as corn, soybeans, and cotton - that help farmers have better harvests while using water and other important resources more efficiently. We work to find sustainable solutions for soil health, help farmers use data to improve farming practices and conserve natural resources, and provide crop protection products to minimize damage from pests and disease. Through programs and partnerships, we collaborate with farmers, researchers, nonprofit organizations, universities and others to help tackle some of the world’s biggest challenges. To learn more about Monsanto, our commitments and our more than 20,000 dedicated employees, please visit: discover.monsanto.com and monsanto.com. Follow our business on Twitter® at twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at monsantoblog.com or subscribe to our News Release RSS Feed.

-oOo-